Clinical features of cerebral cavernous malformations patients with KRIT1 mutations
Cerebral Cavernous Malformations (CCM/OMIM 604214) are vascular malformations causing seizures and cerebral hemorrhages. They occur as a sporadic and autosomal dominant condition, the latter being characterized by the presence of multiple CCM lesions. Stereotyped truncating mutations of KRIT1, the s...
Gespeichert in:
Veröffentlicht in: | Annals of neurology 2004-02, Vol.55 (2), p.213-220 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 220 |
---|---|
container_issue | 2 |
container_start_page | 213 |
container_title | Annals of neurology |
container_volume | 55 |
creator | Denier, Christian Labauge, Pierre Brunereau, Laurent Cavé-Riant, Florence Marchelli, Florence Arnoult, Minh Cecillon, Michaelle Maciazek, Jacqueline Joutel, Anne Tournier-Lasserve, Elisabeth |
description | Cerebral Cavernous Malformations (CCM/OMIM 604214) are vascular malformations causing seizures and cerebral hemorrhages. They occur as a sporadic and autosomal dominant condition, the latter being characterized by the presence of multiple CCM lesions. Stereotyped truncating mutations of KRIT1, the sole CCM gene identified so far, have been identified in CCM1 linked families but the clinical features associated with KRIT1 mutations have not yet been assessed in a large series of patients. We conducted a detailed clinical, neuroradiological and molecular analysis of 64 consecutively recruited CCM families segregating a KRIT1 mutation. Those families included 202 KRIT1 mutation carriers. Among the 202 KRIT1 mutation carriers, 126 individuals were symptomatic and 76 symptom‐free. Mean age at clinical onset was 29.7 years (range, 2–72); initial clinical manifestations were seizures in 55% of the cases and cerebral hemorrhages in 32%. Average number of lesions on T2 weighted MRI was 4.9 (±7.2) and on gradient echo sequences 19.8 (±33.2). Twenty‐six mutation carriers harbored only one lesion on T2‐weighted MRI, including 4 mutation carriers, aged from 18 to 55 yr‐old, who presented only one CCM lesion both on T2‐weighted and on highly sensitive gradient echo MRI sequences. Five symptom free mutation carriers, aged from 27 to 48 yr‐old, did not have any detectable lesion both on T2WI and gradient echo MRI sequences. Within KRIT1/CCM1 families, both clinical and radiological penetrance are incomplete and age dependent. Importantly for genetic counseling, nearly half of the KRIT1 mutation carriers aged 50 or more are symptom‐free. The presence of only one lesion, even when using gradient echo MRI sequences, can be observed in some patients with an hereditary form of the disease. Incomplete neuroradiological penetrance precludes the use of cerebral MRI to firmly establish a non carrier status, even at an adult age and even when using highly sensitive gradient echo MRI. Altogether these data suggest that the hereditary nature of the disorder may be overlooked in some mutation carriers presenting as sporadic cases with a unique lesion. Ann Neurol 2004 |
doi_str_mv | 10.1002/ana.10804 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80132813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80132813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3914-dcdbecbd4fba851e4a9fd9190655fb0e11ad8a31a995021e22acbe10adde1f43</originalsourceid><addsrcrecordid>eNp1kEtv1DAQgC0EokvhwB9AuYDUQ1hPbOdxXC20XbEqEqyExMWaOGNhyGNrJ5T-e1wS2BOnGc1889DH2Evgb4HzbI09xqTk8hFbgRKQlpmsHrMVF7lMFQh5xp6F8J1zXuXAn7IzkIVSRaZW7PO2db0z2CaWcJw8hWSwiSFPtY9Fgz_J98MUkg5bO_gORzf0ITnGSP0Ykjs3fks-fNodIOmmce4-Z08stoFeLPGcHS7fH7bX6f7j1W672adGVCDTxjQ1mbqRtsZSAUmsbFNBxXOlbM0JAJsSBWBVKZ4BZRmamoBj0xBYKc7Zm3nt0Q-3E4VRdy4YalvsKX6sSw4iK0FE8GIGjR9C8GT10bsO_b0Grh8E6ihQ_xEY2VfL0qnuqDmRi7EIvF4ADFGb9dgbF06cKnJZQBm59czduZbu_39Rb242f0-n84QLI_36N4H-h84LUSj95eZK5-orf1eUUhfiN804lzE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80132813</pqid></control><display><type>article</type><title>Clinical features of cerebral cavernous malformations patients with KRIT1 mutations</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Denier, Christian ; Labauge, Pierre ; Brunereau, Laurent ; Cavé-Riant, Florence ; Marchelli, Florence ; Arnoult, Minh ; Cecillon, Michaelle ; Maciazek, Jacqueline ; Joutel, Anne ; Tournier-Lasserve, Elisabeth</creator><creatorcontrib>Denier, Christian ; Labauge, Pierre ; Brunereau, Laurent ; Cavé-Riant, Florence ; Marchelli, Florence ; Arnoult, Minh ; Cecillon, Michaelle ; Maciazek, Jacqueline ; Joutel, Anne ; Tournier-Lasserve, Elisabeth ; Sociéte de Neurochirurgie de Langue Française ; Sociéte Française de Neurochirgurgie</creatorcontrib><description>Cerebral Cavernous Malformations (CCM/OMIM 604214) are vascular malformations causing seizures and cerebral hemorrhages. They occur as a sporadic and autosomal dominant condition, the latter being characterized by the presence of multiple CCM lesions. Stereotyped truncating mutations of KRIT1, the sole CCM gene identified so far, have been identified in CCM1 linked families but the clinical features associated with KRIT1 mutations have not yet been assessed in a large series of patients. We conducted a detailed clinical, neuroradiological and molecular analysis of 64 consecutively recruited CCM families segregating a KRIT1 mutation. Those families included 202 KRIT1 mutation carriers. Among the 202 KRIT1 mutation carriers, 126 individuals were symptomatic and 76 symptom‐free. Mean age at clinical onset was 29.7 years (range, 2–72); initial clinical manifestations were seizures in 55% of the cases and cerebral hemorrhages in 32%. Average number of lesions on T2 weighted MRI was 4.9 (±7.2) and on gradient echo sequences 19.8 (±33.2). Twenty‐six mutation carriers harbored only one lesion on T2‐weighted MRI, including 4 mutation carriers, aged from 18 to 55 yr‐old, who presented only one CCM lesion both on T2‐weighted and on highly sensitive gradient echo MRI sequences. Five symptom free mutation carriers, aged from 27 to 48 yr‐old, did not have any detectable lesion both on T2WI and gradient echo MRI sequences. Within KRIT1/CCM1 families, both clinical and radiological penetrance are incomplete and age dependent. Importantly for genetic counseling, nearly half of the KRIT1 mutation carriers aged 50 or more are symptom‐free. The presence of only one lesion, even when using gradient echo MRI sequences, can be observed in some patients with an hereditary form of the disease. Incomplete neuroradiological penetrance precludes the use of cerebral MRI to firmly establish a non carrier status, even at an adult age and even when using highly sensitive gradient echo MRI. Altogether these data suggest that the hereditary nature of the disorder may be overlooked in some mutation carriers presenting as sporadic cases with a unique lesion. Ann Neurol 2004</description><identifier>ISSN: 0364-5134</identifier><identifier>EISSN: 1531-8249</identifier><identifier>DOI: 10.1002/ana.10804</identifier><identifier>PMID: 14755725</identifier><identifier>CODEN: ANNED3</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Brain - pathology ; Cerebral Hemorrhage - etiology ; Child ; Child, Preschool ; Female ; Hemangioma, Cavernous, Central Nervous System - complications ; Hemangioma, Cavernous, Central Nervous System - genetics ; Hemangioma, Cavernous, Central Nervous System - pathology ; Heterozygote ; Humans ; Infant ; KRIT1 Protein ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Microtubule-Associated Proteins - genetics ; Middle Aged ; Mutation ; Neurology ; Pedigree ; Penetrance ; Polymorphism, Single-Stranded Conformational ; Proto-Oncogene Proteins - genetics ; Seizures - etiology ; Sex Factors</subject><ispartof>Annals of neurology, 2004-02, Vol.55 (2), p.213-220</ispartof><rights>Copyright © 2003 American Neurological Association</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3914-dcdbecbd4fba851e4a9fd9190655fb0e11ad8a31a995021e22acbe10adde1f43</citedby><cites>FETCH-LOGICAL-c3914-dcdbecbd4fba851e4a9fd9190655fb0e11ad8a31a995021e22acbe10adde1f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fana.10804$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fana.10804$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15764718$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14755725$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Denier, Christian</creatorcontrib><creatorcontrib>Labauge, Pierre</creatorcontrib><creatorcontrib>Brunereau, Laurent</creatorcontrib><creatorcontrib>Cavé-Riant, Florence</creatorcontrib><creatorcontrib>Marchelli, Florence</creatorcontrib><creatorcontrib>Arnoult, Minh</creatorcontrib><creatorcontrib>Cecillon, Michaelle</creatorcontrib><creatorcontrib>Maciazek, Jacqueline</creatorcontrib><creatorcontrib>Joutel, Anne</creatorcontrib><creatorcontrib>Tournier-Lasserve, Elisabeth</creatorcontrib><creatorcontrib>Sociéte de Neurochirurgie de Langue Française</creatorcontrib><creatorcontrib>Sociéte Française de Neurochirgurgie</creatorcontrib><title>Clinical features of cerebral cavernous malformations patients with KRIT1 mutations</title><title>Annals of neurology</title><addtitle>Ann Neurol</addtitle><description>Cerebral Cavernous Malformations (CCM/OMIM 604214) are vascular malformations causing seizures and cerebral hemorrhages. They occur as a sporadic and autosomal dominant condition, the latter being characterized by the presence of multiple CCM lesions. Stereotyped truncating mutations of KRIT1, the sole CCM gene identified so far, have been identified in CCM1 linked families but the clinical features associated with KRIT1 mutations have not yet been assessed in a large series of patients. We conducted a detailed clinical, neuroradiological and molecular analysis of 64 consecutively recruited CCM families segregating a KRIT1 mutation. Those families included 202 KRIT1 mutation carriers. Among the 202 KRIT1 mutation carriers, 126 individuals were symptomatic and 76 symptom‐free. Mean age at clinical onset was 29.7 years (range, 2–72); initial clinical manifestations were seizures in 55% of the cases and cerebral hemorrhages in 32%. Average number of lesions on T2 weighted MRI was 4.9 (±7.2) and on gradient echo sequences 19.8 (±33.2). Twenty‐six mutation carriers harbored only one lesion on T2‐weighted MRI, including 4 mutation carriers, aged from 18 to 55 yr‐old, who presented only one CCM lesion both on T2‐weighted and on highly sensitive gradient echo MRI sequences. Five symptom free mutation carriers, aged from 27 to 48 yr‐old, did not have any detectable lesion both on T2WI and gradient echo MRI sequences. Within KRIT1/CCM1 families, both clinical and radiological penetrance are incomplete and age dependent. Importantly for genetic counseling, nearly half of the KRIT1 mutation carriers aged 50 or more are symptom‐free. The presence of only one lesion, even when using gradient echo MRI sequences, can be observed in some patients with an hereditary form of the disease. Incomplete neuroradiological penetrance precludes the use of cerebral MRI to firmly establish a non carrier status, even at an adult age and even when using highly sensitive gradient echo MRI. Altogether these data suggest that the hereditary nature of the disorder may be overlooked in some mutation carriers presenting as sporadic cases with a unique lesion. Ann Neurol 2004</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Brain - pathology</subject><subject>Cerebral Hemorrhage - etiology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>Hemangioma, Cavernous, Central Nervous System - complications</subject><subject>Hemangioma, Cavernous, Central Nervous System - genetics</subject><subject>Hemangioma, Cavernous, Central Nervous System - pathology</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Infant</subject><subject>KRIT1 Protein</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microtubule-Associated Proteins - genetics</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neurology</subject><subject>Pedigree</subject><subject>Penetrance</subject><subject>Polymorphism, Single-Stranded Conformational</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Seizures - etiology</subject><subject>Sex Factors</subject><issn>0364-5134</issn><issn>1531-8249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtv1DAQgC0EokvhwB9AuYDUQ1hPbOdxXC20XbEqEqyExMWaOGNhyGNrJ5T-e1wS2BOnGc1889DH2Evgb4HzbI09xqTk8hFbgRKQlpmsHrMVF7lMFQh5xp6F8J1zXuXAn7IzkIVSRaZW7PO2db0z2CaWcJw8hWSwiSFPtY9Fgz_J98MUkg5bO_gORzf0ITnGSP0Ykjs3fks-fNodIOmmce4-Z08stoFeLPGcHS7fH7bX6f7j1W672adGVCDTxjQ1mbqRtsZSAUmsbFNBxXOlbM0JAJsSBWBVKZ4BZRmamoBj0xBYKc7Zm3nt0Q-3E4VRdy4YalvsKX6sSw4iK0FE8GIGjR9C8GT10bsO_b0Grh8E6ihQ_xEY2VfL0qnuqDmRi7EIvF4ADFGb9dgbF06cKnJZQBm59czduZbu_39Rb242f0-n84QLI_36N4H-h84LUSj95eZK5-orf1eUUhfiN804lzE</recordid><startdate>200402</startdate><enddate>200402</enddate><creator>Denier, Christian</creator><creator>Labauge, Pierre</creator><creator>Brunereau, Laurent</creator><creator>Cavé-Riant, Florence</creator><creator>Marchelli, Florence</creator><creator>Arnoult, Minh</creator><creator>Cecillon, Michaelle</creator><creator>Maciazek, Jacqueline</creator><creator>Joutel, Anne</creator><creator>Tournier-Lasserve, Elisabeth</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Willey-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200402</creationdate><title>Clinical features of cerebral cavernous malformations patients with KRIT1 mutations</title><author>Denier, Christian ; Labauge, Pierre ; Brunereau, Laurent ; Cavé-Riant, Florence ; Marchelli, Florence ; Arnoult, Minh ; Cecillon, Michaelle ; Maciazek, Jacqueline ; Joutel, Anne ; Tournier-Lasserve, Elisabeth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3914-dcdbecbd4fba851e4a9fd9190655fb0e11ad8a31a995021e22acbe10adde1f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Brain - pathology</topic><topic>Cerebral Hemorrhage - etiology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>Hemangioma, Cavernous, Central Nervous System - complications</topic><topic>Hemangioma, Cavernous, Central Nervous System - genetics</topic><topic>Hemangioma, Cavernous, Central Nervous System - pathology</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Infant</topic><topic>KRIT1 Protein</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microtubule-Associated Proteins - genetics</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neurology</topic><topic>Pedigree</topic><topic>Penetrance</topic><topic>Polymorphism, Single-Stranded Conformational</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Seizures - etiology</topic><topic>Sex Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Denier, Christian</creatorcontrib><creatorcontrib>Labauge, Pierre</creatorcontrib><creatorcontrib>Brunereau, Laurent</creatorcontrib><creatorcontrib>Cavé-Riant, Florence</creatorcontrib><creatorcontrib>Marchelli, Florence</creatorcontrib><creatorcontrib>Arnoult, Minh</creatorcontrib><creatorcontrib>Cecillon, Michaelle</creatorcontrib><creatorcontrib>Maciazek, Jacqueline</creatorcontrib><creatorcontrib>Joutel, Anne</creatorcontrib><creatorcontrib>Tournier-Lasserve, Elisabeth</creatorcontrib><creatorcontrib>Sociéte de Neurochirurgie de Langue Française</creatorcontrib><creatorcontrib>Sociéte Française de Neurochirgurgie</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Denier, Christian</au><au>Labauge, Pierre</au><au>Brunereau, Laurent</au><au>Cavé-Riant, Florence</au><au>Marchelli, Florence</au><au>Arnoult, Minh</au><au>Cecillon, Michaelle</au><au>Maciazek, Jacqueline</au><au>Joutel, Anne</au><au>Tournier-Lasserve, Elisabeth</au><aucorp>Sociéte de Neurochirurgie de Langue Française</aucorp><aucorp>Sociéte Française de Neurochirgurgie</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical features of cerebral cavernous malformations patients with KRIT1 mutations</atitle><jtitle>Annals of neurology</jtitle><addtitle>Ann Neurol</addtitle><date>2004-02</date><risdate>2004</risdate><volume>55</volume><issue>2</issue><spage>213</spage><epage>220</epage><pages>213-220</pages><issn>0364-5134</issn><eissn>1531-8249</eissn><coden>ANNED3</coden><abstract>Cerebral Cavernous Malformations (CCM/OMIM 604214) are vascular malformations causing seizures and cerebral hemorrhages. They occur as a sporadic and autosomal dominant condition, the latter being characterized by the presence of multiple CCM lesions. Stereotyped truncating mutations of KRIT1, the sole CCM gene identified so far, have been identified in CCM1 linked families but the clinical features associated with KRIT1 mutations have not yet been assessed in a large series of patients. We conducted a detailed clinical, neuroradiological and molecular analysis of 64 consecutively recruited CCM families segregating a KRIT1 mutation. Those families included 202 KRIT1 mutation carriers. Among the 202 KRIT1 mutation carriers, 126 individuals were symptomatic and 76 symptom‐free. Mean age at clinical onset was 29.7 years (range, 2–72); initial clinical manifestations were seizures in 55% of the cases and cerebral hemorrhages in 32%. Average number of lesions on T2 weighted MRI was 4.9 (±7.2) and on gradient echo sequences 19.8 (±33.2). Twenty‐six mutation carriers harbored only one lesion on T2‐weighted MRI, including 4 mutation carriers, aged from 18 to 55 yr‐old, who presented only one CCM lesion both on T2‐weighted and on highly sensitive gradient echo MRI sequences. Five symptom free mutation carriers, aged from 27 to 48 yr‐old, did not have any detectable lesion both on T2WI and gradient echo MRI sequences. Within KRIT1/CCM1 families, both clinical and radiological penetrance are incomplete and age dependent. Importantly for genetic counseling, nearly half of the KRIT1 mutation carriers aged 50 or more are symptom‐free. The presence of only one lesion, even when using gradient echo MRI sequences, can be observed in some patients with an hereditary form of the disease. Incomplete neuroradiological penetrance precludes the use of cerebral MRI to firmly establish a non carrier status, even at an adult age and even when using highly sensitive gradient echo MRI. Altogether these data suggest that the hereditary nature of the disorder may be overlooked in some mutation carriers presenting as sporadic cases with a unique lesion. Ann Neurol 2004</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>14755725</pmid><doi>10.1002/ana.10804</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0364-5134 |
ispartof | Annals of neurology, 2004-02, Vol.55 (2), p.213-220 |
issn | 0364-5134 1531-8249 |
language | eng |
recordid | cdi_proquest_miscellaneous_80132813 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adolescent Adult Aged Biological and medical sciences Brain - pathology Cerebral Hemorrhage - etiology Child Child, Preschool Female Hemangioma, Cavernous, Central Nervous System - complications Hemangioma, Cavernous, Central Nervous System - genetics Hemangioma, Cavernous, Central Nervous System - pathology Heterozygote Humans Infant KRIT1 Protein Magnetic Resonance Imaging Male Medical sciences Microtubule-Associated Proteins - genetics Middle Aged Mutation Neurology Pedigree Penetrance Polymorphism, Single-Stranded Conformational Proto-Oncogene Proteins - genetics Seizures - etiology Sex Factors |
title | Clinical features of cerebral cavernous malformations patients with KRIT1 mutations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T08%3A21%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20features%20of%20cerebral%20cavernous%20malformations%20patients%20with%20KRIT1%20mutations&rft.jtitle=Annals%20of%20neurology&rft.au=Denier,%20Christian&rft.aucorp=Soci%C3%A9te%20de%20Neurochirurgie%20de%20Langue%20Fran%C3%A7aise&rft.date=2004-02&rft.volume=55&rft.issue=2&rft.spage=213&rft.epage=220&rft.pages=213-220&rft.issn=0364-5134&rft.eissn=1531-8249&rft.coden=ANNED3&rft_id=info:doi/10.1002/ana.10804&rft_dat=%3Cproquest_cross%3E80132813%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80132813&rft_id=info:pmid/14755725&rfr_iscdi=true |